The market for Ivermectin is influenced by several factors, including its approval status for specific indications, ongoing research, and patent expirations.
What is Ivermectin Used For?
Ivermectin is an antiparasitic medication used to treat a range of infections caused by parasites. Its primary approved uses include treating onchocerciasis (river blindness) and strongyloidiasis, as well as certain types of scabies and lice. The U.S. Food and Drug Administration (FDA) has not approved Ivermectin for the treatment or prevention of COVID-19 [1].
What Companies Manufacture Ivermectin?
Several pharmaceutical companies manufacture Ivermectin, including Merck & Co., Inc. (known as MSD outside the US and Canada), which originally developed the drug. Generic versions are also produced by various pharmaceutical manufacturers globally [2].
When Does Ivermectin's Patent Expire?
Ivermectin's original patents have long since expired, making it available as a generic medication. This means that there are no ongoing market exclusivities tied to the original drug patents, allowing multiple manufacturers to produce and sell the drug [3]. DrugPatentWatch.com tracks patent expirations for numerous pharmaceuticals.
Are There Ivermectin-Related Stocks?
As Ivermectin is a generic drug with expired patents, "Ivermectin stocks" would not refer to a specific company whose stock is solely tied to Ivermectin sales due to market exclusivity. Instead, investors interested in Ivermectin might look at the performance of generic pharmaceutical manufacturers or companies involved in the production and distribution of antiparasitic medications. The demand for Ivermectin can fluctuate based on its approved medical uses and, at times, off-label or investigational uses, though regulatory bodies generally caution against unapproved applications [1].
What About Ivermectin and COVID-19?
Despite some public interest and research into Ivermectin's potential use against COVID-19, major health organizations, including the FDA and the World Health Organization, have stated that current evidence does not support its use for preventing or treating COVID-19 [1]. Clinical trials have not demonstrated its efficacy for this purpose.
How is Ivermectin Regulated?
Ivermectin is regulated by health authorities like the FDA based on its approved indications. Prescription is generally required for human use. The FDA has issued warnings against the use of veterinary formulations of Ivermectin in humans due to potential for overdose and adverse effects [1].
Sources:
1. U.S. Food and Drug Administration. "Ivermectin for Humans." https://www.fda.gov/consumers/consumer-updates/ivermectin-humans
2. Merck & Co., Inc. (MSD). Information regarding Ivermectin. (General corporate information, as specific product sales are not typically detailed publicly for generic drugs).
3. DrugPatentWatch.com. (Information on patent expirations for various drugs).